BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Shanghai
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:CST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Pacific/Easter
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:-06
DTSTART:20230402T030000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:-05
DTSTART:20230903T040000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:-06
DTSTART:20240407T030000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:-05
DTSTART:20240908T040000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:-06
DTSTART:20250406T030000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:-05
DTSTART:20250907T040000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20241216T190000
DTEND;TZID=Asia/Shanghai:20241216T210000
DTSTAMP:20260404T101947
CREATED:20241208T194711Z
LAST-MODIFIED:20250608T082025Z
UID:10000096-1734375600-1734382800@oncodaily.com
SUMMARY:SE Asia Course II: Immunotherapy in Lung Cancer By IASLC
DESCRIPTION:SE Asia Course II: Immunotherapy in Lung Cancer By IASLC will be held on December 16th\, 2024. \nThis exclusive course will offer the latest updates on lung cancer treatment in Southeast Asia\, with a special focus on immunotherapy. In Series II\, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy\, the best management strategies for advanced disease\, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy is set to transform the landscape of lung cancer treatment in Southeast Asia\, bringing hope for improved patient outcomes. \nSee the Speakers and Southeast Asia Team Below:
URL:https://oncodaily.com/event/200336
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/RegionalSeries_SocialMedia_SEAsia_1920x1080.jpg
ORGANIZER;CN="The International Association for the Study of Lung Cancer (IASLC)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241211T080000
DTEND;TZID=Europe/Helsinki:20241213T160000
DTSTAMP:20260404T101947
CREATED:20241007T163026Z
LAST-MODIFIED:20250608T081714Z
UID:10000016-1733904000-1734105600@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2024
DESCRIPTION:Join the ESMO Immuno-Oncology Congress 2024\, happening in Palexpo exhibition Centre in Geneva\, Switzerland\, and online on 11-13 December. This international event features a comprehensive educational program and highlights the latest scientific advancements in the rapidly evolving field of immunotherapy. It is organized by the European Society for Medical Oncology. \nWhether you’re looking to grasp the fundamentals of immunotherapies or delve into cutting-edge research\, this congress will address a wide range of topics—from treatment options to managing toxicities and interpreting new data. It’s designed to meet the diverse needs of all oncology stakeholders. \nDon’t miss this opportunity to learn\, share your research\, and connect with leaders who are shaping the future of cancer treatment. Find the registration link here. \nMore information featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/159712
LOCATION:Palexpo exhibition centre\, 30 Route François-Peyrot \, Geneva\, 1218\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Vignette-agenda-Palexpo-12.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241211T060000
DTEND;TZID=America/Halifax:20241211T080000
DTSTAMP:20260404T101947
CREATED:20241202T125502Z
LAST-MODIFIED:20250608T081720Z
UID:10000080-1733896800-1733904000@oncodaily.com
SUMMARY:3rd APHOG Global Seminar 2024
DESCRIPTION:3rd APHOG (Asian Pediatric Hematology and Oncology Group) Global Seminar 2024 is a Virtual Event that will be held at December 11. 2024. \nThe 3rd APHOG (Asian Pediatric Hematology and Oncology Group) Global Seminar 2024 focuses on “Soft Tissue Sarcoma: Asian Challenge.” This event aims to address the growing concern of soft tissue sarcomas (STS) in pediatric oncology across Asia. Experts and healthcare professionals from various countries will come together to discuss the latest advancements in the diagnosis\, treatment\, and management of soft tissue sarcomas in children and adolescents. The seminar will feature presentations on clinical research\, emerging therapies\, and the unique challenges faced by Asian countries in combating this rare and complex cancer. Additionally\, the event will emphasize the importance of collaboration and knowledge exchange to improve outcomes and provide better care for pediatric sarcoma patients in the region. \nFor Registration Visit Here.
URL:https://oncodaily.com/event/193636
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/329273_50442edf84564ce9a358766822966044mv2-e1732821881607.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241210T093000
DTEND;TZID=America/Halifax:20241211T153000
DTSTAMP:20260404T101947
CREATED:20241209T142331Z
LAST-MODIFIED:20250608T081727Z
UID:10000099-1733823000-1733931000@oncodaily.com
SUMMARY:NCI Cancer Integrative Medicine Grantee Virtual Conference
DESCRIPTION:NCI Cancer Integrative Medicine Grantee Virtual Conference will be held from December 10-11\, 2024. \n\n\n\n\nThis open-to-the-public event\, with registration required\, will focus on the integration of conventional cancer treatments with complementary therapies to improve patient outcomes and quality of life. \nThe conference aims to achieve two main objectives: \n\nGrantsmanship: It will provide valuable learning opportunities regarding grantsmanship\, tools\, and resources from NCI/NIH\, while also allowing NCI program staff to hear directly from grantees about their needs and challenges.\nResearch: The event will showcase NCI/NIH-funded research on cancer-related complementary and integrative medicine. It will highlight key findings and identify gaps or needs for advancing translational and clinical research in integrative oncology\, especially in advancing precision medicine across the cancer continuum.\n\nThe conference will play a crucial role in advancing the understanding and practice of integrative oncology\, which combines standard cancer therapies with complementary methods such as acupuncture\, herbal medicine\, lifestyle changes\, and mind-body techniques. The goal is to enhance both the physical and emotional well-being of cancer patients\, improving overall therapeutic outcomes. \n\n\n\n\nRegistration is Open.
URL:https://oncodaily.com/event/200593
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/1733670025234-e1733753597281.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241210T000000
DTEND;TZID=America/Halifax:20241213T190000
DTSTAMP:20260404T101947
CREATED:20241025T133551Z
LAST-MODIFIED:20250608T081734Z
UID:10000054-1733788800-1734116400@oncodaily.com
SUMMARY:The San Antonio Breast Cancer Symposium (SABCS) 2024
DESCRIPTION:The San Antonio Breast Cancer Symposium (SABCS) 2024 is scheduled to take place from December 10 to December 13\, 2024\, at San Antonio\, Texas. \nThe event will focus on the latest advancements in breast cancer research and treatments. SABCS 2024 will be available both in-person and virtually\, providing flexible options for attendees to engage with the program. The 2024 SABCS will have new sessions offering the latest in breast cancer science and research. \nFor registration visit here \n  \n 
URL:https://oncodaily.com/event/169314
LOCATION:Henry B. Gonzalez Convention Center in San Antonio\, 900 E Market St\, San Antonio\, San Antonio\, TX\, 78205-2784
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/WhatsApp-Image-2024-11-06-at-13.03.54.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Pacific/Easter:20241208T150000
DTEND;TZID=Pacific/Easter:20241208T170000
DTSTAMP:20260404T101947
CREATED:20241205T121900Z
LAST-MODIFIED:20250608T081741Z
UID:10000088-1733670000-1733677200@oncodaily.com
SUMMARY:IOWG Grand Rounds - A Tale of Two Cancer Centers: Building Integrative Oncology Programs at Two Leading Institutions DFCI and Fred Hutch
DESCRIPTION:IOWG Grand Rounds – A Tale of Two Cancer Centers: Building Integrative Oncology Programs at Two Leading Institutions DFCI and Fred Hutch will be held at December 8th\, 2024. \nIt is a Live Webinar will feature expert presentations from Dr. Ting Bao\, Dr. Heather Greenlee\, and Kathleen Sanders\, who will provide valuable perspectives on integrating complementary therapies with traditional cancer treatments. Their work focuses on improving patient outcomes by addressing the whole person—body\, mind\, and spirit—through a combination of evidence-based medicine and holistic approaches. \nIn this insightful discussion\, the speakers will explore the origins and development of integrative oncology programs at two major U.S. cancer centers: the Zakim Center at Dana-Farber Cancer Institute and the Integrative Medicine Program at Fred Hutchinson Cancer Center. They will share behind-the-scenes stories on how these pioneering centers were established\, highlighting the challenges and successes in building comprehensive integrative oncology services. The session will also delve into specific initiatives like Dr. Ting Bao’s role in setting up the Physician Consult Service at Dana-Farber\, the development of the MyZakim website\, and Fred Hutch’s “Cook for Your Life” website\, which provides cancer patients with essential nutrition resources. \n\n\n\n\nThe webinar will discuss the Dietary Supplement Review program at Fred Hutch\, ensuring patient safety while incorporating supplements into cancer care. Attendees will gain valuable insights into the history and evolution of these programs\, learning practical strategies that have enhanced patient care through integrative approaches. This session will showcase how these institutions have shaped the field of integrative oncology and continue to improve the quality of life for cancer patients through innovation and patient-centered care. \nThe ones who join will have the opportunity to learn about the cutting-edge practices implemented at Dana-Farber and Fred Hutchinson\, explore how digital resources can enhance patient care\, and gain practical tools to integrate these strategies into their own practice. This is an unmissable event for healthcare providers interested in advancing integrative oncology and improving the overall care and quality of life for cancer patients. \n\n\n\n\nVisit the link for Registration.
URL:https://oncodaily.com/event/197721
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Untitled-11-3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241207T000000
DTEND;TZID=America/Halifax:20241210T000000
DTSTAMP:20260404T101947
CREATED:20241020T204011Z
LAST-MODIFIED:20250608T081748Z
UID:10000053-1733529600-1733788800@oncodaily.com
SUMMARY:The 66th ASH Annual Meeting and Exposition
DESCRIPTION:The 66th ASH Annual Meeting and Exposition will take place from December 7-10\, 2024\, in San Diego\, California\, and online. \nThe ASH annual meeting is the world’s largest and most comprehensive hematology event of the year. With hundreds of sessions on the hottest trends in hematology\, ASH offers multiple ways for attendees to find exactly what they are looking for. Education Program sessions consist of didactic presentations followed by panel discussions and a question-and-answer period with all of the speakers. Mark your calendars now to attend the world’s most comprehensive hematology event of the year. \nFor registration visit here \n 
URL:https://oncodaily.com/event/169244
LOCATION:The Marriott Marquis San Diego Marina\, 333 W Harbor Dr\, San Diego\, San Diego\, 92101\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/download-40.png
ORGANIZER;CN="American Society of Hematology":MAILTO:customerservice@hematology.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20241206T100000
DTEND;TZID=Asia/Shanghai:20241208T160000
DTSTAMP:20260404T101947
CREATED:20241007T161712Z
LAST-MODIFIED:20250608T081755Z
UID:10000015-1733479200-1733673600@oncodaily.com
SUMMARY:ESMO Asia Congress 2024
DESCRIPTION:The ESMO Asia Congress 2024 will be held at the Suntec Singapore Convention & Exhibition Centre\, Singapore\, on December 6-8. It is organized by the European Society for Medical Oncology. \nThis key event brings together oncologists\, researchers\, and healthcare professionals from Asia and beyond to share the latest in cancer research\, clinical trials\, and treatment strategies. \nAttendees can look forward to a range of scientific sessions covering key topics in oncology\, including new research findings and innovative treatment approaches. There will also be educational sessions aimed at providing practical insights that participants can apply in their everyday practice. \nDon’t miss this opportunity to connect with peers and shape the future of cancer care in the region! \nRegister here. \nFind more information featuring the Congress at OncoDaily.com.
URL:https://oncodaily.com/event/159674
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard\, Suntec City\, 039593\, Singapore
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/ESMO-ASIA-Congress-2024-FB-LI-1200x628-Register.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241206T000000
DTEND;TZID=America/Halifax:20241208T000000
DTSTAMP:20260404T101947
CREATED:20241123T195938Z
LAST-MODIFIED:20250608T081802Z
UID:10000074-1733443200-1733616000@oncodaily.com
SUMMARY:Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer by OncoDaily
DESCRIPTION:Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer by OncoDaily will be held from December 6-8\, 2024. \nWe are honored to invite you to the inaugural event of the Global Cancer Movement\, an initiative by OncoDaily\, aimed at advancing global collaboration in cancer research\, treatment\, and advocacy. \nThis three-day virtual event will bring together a diverse range of experts\, including leading oncologists\, researchers\, patients\, advocates\, and key figures from international health organizations. Together\, they will explore the current state of colorectal cancer\, addressing both the challenges and opportunities in the fight against this prevalent disease. The event will provide a platform for engaging discussions on the latest scientific research\, breakthrough therapies\, and global health strategies aimed at improving patient outcomes. It will also focus on how to stimulate innovation in colorectal cancer care\, enhance early detection\, and ensure equitable access to treatment for all patients. Participants will have the opportunity to collaborate\, share knowledge\, and shape the future of colorectal cancer treatment and advocacy. \nRegister here as we strive to create a meaningful impact and drive progress in this critical area of oncology. \n 
URL:https://oncodaily.com/event/188407
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/IMG_1652.jpg
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241205T000000
DTEND;TZID=America/Halifax:20241207T000000
DTSTAMP:20260404T101947
CREATED:20241202T125648Z
LAST-MODIFIED:20250608T081809Z
UID:10000079-1733356800-1733529600@oncodaily.com
SUMMARY:The AORTIC PALOP VI Conference
DESCRIPTION:The AORTIC PALOP VI Conference will be held from 5-7 December\, 2024 at Luanda\, Angola. \nThe AORTIC PALOP VI Conference focuses on advancing cancer research and care in Portuguese-speaking African countries (PALOP). Organized by the African Organisation for Research and Training in Cancer (AORTIC)\, the event brings together healthcare professionals\, researchers\, and policymakers to discuss cancer prevention\, diagnosis\, and treatment. It addresses the unique challenges faced by PALOP nations\, such as limited resources and access to care\, while promoting collaboration and knowledge-sharing to improve cancer outcomes. The conference aims to strengthen healthcare systems and enhance research efforts to combat cancer in these regions. \nRegistration to Attend the In-Person Meeting is free and Here is the Link.
URL:https://oncodaily.com/event/193595
LOCATION:Hospital Cardeal Dom Alexandro Do Nascimento\, Luanda\, Palanca\, Luanda\, Angola
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/1732792207354.jpg
ORGANIZER;CN="AORTIC":MAILTO:info@aortic-africa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241204T080000
DTEND;TZID=America/Halifax:20241204T170000
DTSTAMP:20260404T101947
CREATED:20241205T121712Z
LAST-MODIFIED:20250608T081816Z
UID:10000089-1733299200-1733331600@oncodaily.com
SUMMARY:NFCR Global Summit 2025
DESCRIPTION:NFCR Global Summit and Award Ceremonies For Cancer Research and Entrepreneurship will be held at October 24\, 2025. \nThe Asian Fund for Cancer Research\, National Foundation for Cancer Research\, and AIM-HI Accelerator Fund are co-hosting a dynamic event that will spotlight groundbreaking cancer research discoveries and the transformative impact of oncology innovation. This content-rich event will feature key programs such as New Frontiers in Cancer Research\, the Women’s Leadership and Entrepreneurship Award Ceremony\, the Innovative Oncology Company Showcase\, and the Szent-Györgyi Prize Award Ceremony. \nTaking place live in Washington\, DC\, USA\, the event will bring together a diverse audience\, including cancer research donors\, patients\, academic and industry professionals\, and members of the public interested in learning about the latest advancements in cancer research and the cutting-edge products and tools that are revolutionizing cancer treatment. Attendees will have the opportunity to engage with leading experts and innovators\, gaining valuable insights into the future of cancer care.
URL:https://oncodaily.com/event/197736
LOCATION:Washington\, DC\, Washington\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/09/channels4_profile-e1737808376721.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241202T130000
DTEND;TZID=America/New_York:20241202T163000
DTSTAMP:20260404T101947
CREATED:20241202T184233Z
LAST-MODIFIED:20250608T081822Z
UID:10000084-1733144400-1733157000@oncodaily.com
SUMMARY:NCCIH 25th Anniversary Celebration
DESCRIPTION:The National Center for Complementary and Integrative Health (NCCIH) will celebrate its 25th anniversary by hosting a half-day symposium titled “Exploring the Impact of Whole Person Health” on Monday\, December 2\, 2024 at Bethesda\, Maryland or Virtually. \nThe event will feature the prestigious Stephen E. Straus Distinguished Lecture in the Science of Complementary Therapies\, delivered by Patricia M. Herman\, N.D.\, Ph.D. The lecture is titled “The Economic Impact of Whole Person Health\,” offering valuable insights into the economic aspects of integrative and holistic health approaches. \nNCCIH 25th Anniversary Celebration will include two important sessions: “The Potential Clinical Impact of Whole Person Health\,” which will explore how whole person health care can transform clinical practice\, and “The Challenges and Promise of Whole Person Health Research\,” which will examine the current obstacles and future possibilities for advancing research in this field. The event is aimed at researchers\, clinicians\, policymakers\, and the general public\, providing a platform to share knowledge and ideas. \nA reception will follow the symposium\, offering an opportunity for networking and further discussion. Interested attendees are encouraged to register to secure their participation in this significant event.
URL:https://oncodaily.com/event/196179
LOCATION:Lipsett Amphitheater\, Building 10\, NIH Campus\, 9000 Rockville Pike\, Bethesda\, Maryland\, Bethesda\, Maryland\, MD\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/nccih-25th-anniversary-social-01.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241127T180000
DTEND;TZID=America/Halifax:20241127T193000
DTSTAMP:20260404T101947
CREATED:20241120T051946Z
LAST-MODIFIED:20250608T081829Z
UID:10000071-1732730400-1732735800@oncodaily.com
SUMMARY:Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC
DESCRIPTION:Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27\, 2024. \nIt is a live webinar by SPCC and the event will feature presentations on the latest advancements in breast cancer treatment\, with an introduction by Fiorita Poulakaki from Greece. Michael Gnant from Austria will discuss the de-escalation and escalation of surgery\, radiotherapy\, and adjuvant treatments. Stephen Johnston from the UK will focus on personalizing adjuvant endocrine therapy\, exploring current perspectives and future directions. Following the talks\, there will be a 10-minute discussion and Q&A session\, allowing participants to engage with the speakers. \nThe event will conclude with closing remarks by Fiorita Poulakaki\, summarizing the key takeaways.
URL:https://oncodaily.com/event/188391
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/Webinar_27_Nov_1920x1080.png
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241120T090000
DTEND;TZID=Europe/Brussels:20241121T183000
DTSTAMP:20260404T101947
CREATED:20240927T173111Z
LAST-MODIFIED:20250608T081836Z
UID:10000006-1732093200-1732213800@oncodaily.com
SUMMARY:European Cancer Summit 2024
DESCRIPTION:The European Cancer Summit 2024 will once again unite the cancer community in accelerating efforts against a most relentless disease. Experts\, patients and policymakers will explore new innovative solutions to pressing challenges faced by healthcare systems across Europe and propose new opportunities in cancer research. \nThis year’s European Cancer Summit takes place on 20 & 21 November\, in Brussels & online. \n 
URL:https://oncodaily.com/event/european-cancer-summit-2024
LOCATION:Radisson Collection Hotel Brussels\, 47 Rue du Fossé Aux Loups\, Brussels\, Brussels\, 1000\, Belgium
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/09/ECS.jpg
ORGANIZER;CN="European Cancer Organization":MAILTO:summit@europeancancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241115T000000
DTEND;TZID=Europe/Helsinki:20241117T000000
DTSTAMP:20260404T101947
CREATED:20241016T122837Z
LAST-MODIFIED:20250608T081843Z
UID:10000038-1731628800-1731801600@oncodaily.com
SUMMARY:ESH-EBMT-EHA-IPIG 3rd Translational Research Conference
DESCRIPTION:The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris\, France from November 15-17\, 2024. \nIt will offer valuable insights for both clinical and non-clinical scientists\, including M.D.s and Ph.D.s of all levels\, who are interested in the biology\, pathophysiology\, diagnosis\, and treatment of bone marrow failure syndromes (BMFS) and predisposition syndromes. The conference will address both acquired and inherited BMFS in adults and children\, with a particular focus on emerging principles and innovative treatment strategies. \nAs is customary for ESH\, the event will prioritize accessible interactions between young researchers and established experts\, as well as between clinicians and basic scientists. Workshops with experts and poster walks will emphasize key topics and provide opportunities for in-depth discussion. The distinguished faculty will ensure a high standard of clinical\, translational\, and basic research is maintained throughout the conference. \nFor Registration Visit Here
URL:https://oncodaily.com/event/165887
LOCATION:Espace Saint-Martin\, 199 Bis r St Martin\, 75003 Paris\, Paris\, 75001\, Sweden
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/BMFS2024_banner_NEW.png
ORGANIZER;CN="European School of Haematology":MAILTO:info(at)esh.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241114T120000
DTEND;TZID=America/Halifax:20241117T120000
DTSTAMP:20260404T101947
CREATED:20241102T163359Z
LAST-MODIFIED:20250608T081850Z
UID:10000067-1731585600-1731844800@oncodaily.com
SUMMARY:The 2024 China Conference on Integrative Oncology
DESCRIPTION:The 2024 China Conference on Integrative Oncology will be held from November 14-17\, 2024 at Xi’an\, China. \nOrganized by the China Anti-Cancer Association\, Xijing Hospital of the Air Force Medical University\, and others\, the conference is expected to draw over 40\,000 domestic and 20\,000 international participants. Under the theme “Cancer Prevention and Treatment\, Winning in Integration\,” the event will feature three main sections: “conference\,” “exhibition\,” and “production\,” encompassing academic exchanges\, achievement showcases\, and industrial collaboration. Oncology professionals are encouraged to submit papers and actively participate in this important event. \n 
URL:https://oncodaily.com/event/177006
LOCATION:Xi’an\, China\, Xi'an\, 710000\, China
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/download.png
ORGANIZER;CN="China Anti-Cancer Association":MAILTO:intl@caca.org.cn.
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241114T080000
DTEND;TZID=America/New_York:20241116T163000
DTSTAMP:20260404T101947
CREATED:20241007T145835Z
LAST-MODIFIED:20250608T081857Z
UID:10000013-1731571200-1731774600@oncodaily.com
SUMMARY:2024 Latin America Conference on Lung Cancer
DESCRIPTION:The IASLC Latin America Conference on Lung Cancer (LALCA24) will be held at the Grand Hyatt Bogotá in Bogotá\, Colombia on November 14-16. \nLALCA is a vibrant conference with a rich history that will showcase the latest research\, a variety of relevant topics\, and educational sessions led by top experts. \nThis event offers an excellent chance to connect with professionals from different fields who are dedicated to thoracic cancers\, while also gaining insights into the newest advancements in prevention\, detection\, and treatment through innovative data presentations. \nThe event is organized by the International Association for the Study of Lung Cancer (IASCL). \nFor more information featuring LALCA24 visit OncoDaily.com.
URL:https://oncodaily.com/event/159102
LOCATION:Grand Hyatt Bogotá\, Cl. 24a #57 – 60\, Bogota\, Colombia
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/GPZHUUqaAAAnKPv.jpg
ORGANIZER;CN="International Association for the Study of Lung Cancer (IASCL)":MAILTO:info@iaslc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241113T000000
DTEND;TZID=America/Halifax:20241115T000000
DTSTAMP:20260404T101947
CREATED:20241025T133346Z
LAST-MODIFIED:20250608T081918Z
UID:10000059-1731456000-1731628800@oncodaily.com
SUMMARY:42nd Annual CFS: Innovative Cancer Therapy for Tomorrow
DESCRIPTION:42nd Annual CFS: Innovative Cancer Therapy for Tomorrow will be held from November 13-15\, 2024 at New York\, USA. \n\n\n\n\nEntering its 42nd year\, the Chemotherapy Foundation Symposium (CFS) remains a premier event that brings together thousands of healthcare professionals for a dynamic 3-day conference focused on delivering cutting-edge\, evidence-based cancer care. Esteemed faculty from around the world will share their expertise on the latest developments in cancer therapeutics\, providing attendees with a unique opportunity to explore how new and innovative approaches can be integrated into current treatment paradigms to improve care for cancer patients. \nWith ongoing rapid progress in the management of solid and hematologic malignancies\, the past year has seen significant shifts in practice\, with new diagnostic\, therapeutic\, and supportive care strategies being implemented. At CFS\, participants will gain critical insights into optimized treatments\, including chemotherapies\, targeted therapies\, immunotherapies\, and multimodal approaches that are shaping the future of oncology care.
URL:https://oncodaily.com/event/170152
LOCATION:New York Hilton Midtown\, Grand Ballroom (Located on the 3 rd Floor) 1335 Avenue of the Americas\, New York\, 10019\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/s6x5uyhoplpn-CFS24TIDetail800x450.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241111T083000
DTEND;TZID=UTC:20241115T220000
DTSTAMP:20260404T101947
CREATED:20241101T190154Z
LAST-MODIFIED:20250608T081924Z
UID:10000066-1731313800-1731708000@oncodaily.com
SUMMARY:London Global Cancer Week 2024
DESCRIPTION:London Global Cancer Week 2024 will be held from November 11-15\, 2024 at London\, UK. \nIn 2016\, the Royal Society of Medicine Oncology Section initiated annual one-day meetings aimed at improving global cancer outcomes. This evolved into London Global Cancer Week in 2019\, expanding the format to a week-long series of multidisciplinary meetings that address the global challenges of cancer. Since its launch\, London Global Cancer Week has grown annually\, and in 2024\, it will feature more presentations and speakers than ever before. \nLondon Global Cancer Week will feature a diverse series of events hosted by experts committed to improving global cancer outcomes showcasing innovative solutions and progress in cancer control initiatives fostering coherent policymaking through holistic discussions acting as a catalyst for positive change benefiting individuals and families affected by cancer with no charge for organizations to present or attendees to participate. \nFor programme of the event\, visit here.
URL:https://oncodaily.com/event/176990
LOCATION:The Royal Marsden Education and Conference Centre\, Fulham Road London SW3 6JJ\, London\, United Kingdom
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/11/download-7.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241108T203000
DTEND;TZID=Europe/Helsinki:20241112T130000
DTSTAMP:20260404T101947
CREATED:20241025T133432Z
LAST-MODIFIED:20250608T081913Z
UID:10000052-1731097800-1731416400@oncodaily.com
SUMMARY:15th ESO-EONS Masterclass in Oncology Nursing
DESCRIPTION:15th ESO-EONS Masterclass in Oncology Nursing will be held on San Servolo (Venice)\, Italy from November 8-11\, 2024. \nThe ESO Masterclass in Oncology Nursing is an intensive programme for European cancer nurses\, offering three and a half days of immersive oncology education. It focuses on enhancing clinical skills\, improving patient care\, and advancing clinical leadership. \nNursing sessions will cover key areas such as patient assessment\, safety\, communication\, symptom management\, and nursing research. Case studies presented by participants will explore specialized care practices. \nJoint sessions with physicians emphasize the need for interdisciplinary collaboration in cancer care\, while practical training in case studies will focus on essential skills for patient care management. \nDeadline for applications: Friday 24 May 2024
URL:https://oncodaily.com/event/168621
LOCATION:San Servolo\, San Servolo\, 20100\, Italy
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/Untitled-1f.png
ORGANIZER;CN="European School of Oncology":MAILTO:eso@eso.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241107T090000
DTEND;TZID=Europe/Helsinki:20241108T000000
DTSTAMP:20260404T101947
CREATED:20241020T202240Z
LAST-MODIFIED:20250608T081905Z
UID:10000049-1730970000-1731024000@oncodaily.com
SUMMARY:Frontiers in gynaecological oncology
DESCRIPTION:Frontiers in gynaecological oncology will be held at Pristina\, Kosovo from November 7-8\, 2024. \nThe European School of Oncology offers support to Clinical Institutes through its Visiting Professorship Meeting (VPM) initiative. This program is designed for renowned clinical oncology centers whose medical teams are interested in participating in internal educational meetings conducted in English. \n 
URL:https://oncodaily.com/event/168011
LOCATION:Pristina\, Kosovo\, Pristina\, 10000
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Untitled-2ի-1.jpg
ORGANIZER;CN="European School of Oncology":MAILTO:eso@eso.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241107T080000
DTEND;TZID=Europe/Helsinki:20241110T170000
DTSTAMP:20260404T101947
CREATED:20241029T192326Z
LAST-MODIFIED:20250608T081133Z
UID:10000064-1730966400-1731258000@oncodaily.com
SUMMARY:16th European Multidisciplinary Congress on Urological Cancers EMUC 2024
DESCRIPTION:16th European Multidisciplinary Congress on Urological Cancers EMUC 2024 will take place in Lisbon\, Portugal\, from 7 to 10 November 2024. \nTop experts in medical oncology\, pathology\, radiation oncology\, radiology\, nuclear medicine\, and urology gathered at the EMUC24 congress from 7 to 10 November 2024 to share insights on best practices\, major trial developments\, and breakthroughs. \nThe scientific programme featured in-depth lectures\, practical hands-on courses\, and dynamic multidisciplinary case discussions. EMUC24 highlighted cutting-edge therapies\, current practices\, controversies\, and emerging technologies in GU cancer treatment. \nThis multidisciplinary approach was achieved through collaboration with the European Society for Medical Oncology (ESMO)\, the European Society for Radiotherapy and Oncology (ESTRO)\, and the European Association of Urology (EAU)\, alongside contributions from the Kidney Cancer Association (KCA) on recent kidney cancer advancements.
URL:https://oncodaily.com/event/174661
LOCATION:Lisbon Congress Centre\, Praça das Indústrias 1\, Lisbon\, 1300-307\, Portugal
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Esmou.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241106T070000
DTEND;TZID=America/Halifax:20241106T210000
DTSTAMP:20260404T101947
CREATED:20241031T194019Z
LAST-MODIFIED:20250608T081127Z
UID:10000065-1730876400-1730926800@oncodaily.com
SUMMARY:4th APHOG & SIOP Asia Joint Scientific Symposium 2024 on Retinoblastoma
DESCRIPTION:The 4th APHOG & SIOP Asia Joint Scientific Symposium 2024 will focus on the topic of Retinoblastoma. This event will take place via Zoom on Wednesday\, November 6\, 2024. The session will be held from 07:00 to 09:00 EST (USA)\, 16:30 to 18:30 IST (India)\, and 20:00 to 22:00 JST (Japan). \nThe organizers of the event are the Asian Continental Branch International Society of Pediatric Oncology (SIOP Asia) and the Asian Pediatric Hematology and Oncology Group (APHOG). For more information about the agenda\, check the flyer. \nJoin this important symposium\, where experts from across the region will share insights and advancements in research and treatment. Don’t miss this opportunity to engage in meaningful discussions and expand your knowledge on this critical topic! \nMake sure to register here. \nFind more information featuring SIOP Asia at OncoDaily.
URL:https://oncodaily.com/event/siopasia176544
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/siopasia.jpg
ORGANIZER;CN="SIOP Asia":MAILTO:info@siop-online.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241105T180000
DTEND;TZID=America/Halifax:20241105T180000
DTSTAMP:20260404T101947
CREATED:20241025T133325Z
LAST-MODIFIED:20250608T081121Z
UID:10000061-1730829600-1730829600@oncodaily.com
SUMMARY:Lung cancer highlights from the ESMO Congress 2024 by SPCC
DESCRIPTION:Lung cancer highlights from the ESMO Congress 2024 by SPCC will take place at November 5th\, 2024. \nIt is a live webinar by SPCC which will be futuring Aleksandra Filipovic\, Alfredo Addeo\, Christian Rolfo. The landscape of treatment for thoracic malignancies has undergone significant and rapid advancements in recent years. New therapies\, including targeted treatments\, immunotherapies\, and innovative surgical techniques\, are now available\, having a profound and positive impact on patients’ lives by improving outcomes and quality of care. However\, with the fast-paced development and the vast amount of clinical data being generated from ongoing research and presented at international conferences\, it can be challenging for clinicians and healthcare professionals to stay up to date with the latest evidence and treatment options. \nFor registration visit here
URL:https://oncodaily.com/event/171740
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Webinar_05_Nov_1920x1080.jpg
ORGANIZER;CN="Sharing Progress in Cancer Care":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241101T083000
DTEND;TZID=Europe/Helsinki:20241103T123000
DTSTAMP:20260404T101947
CREATED:20241015T190657Z
LAST-MODIFIED:20250608T081113Z
UID:10000037-1730449800-1730637000@oncodaily.com
SUMMARY:ESH 4th How to Diagnose and Treat Lymphoma
DESCRIPTION:ESH 4th How to Diagnose and Treat Lymphoma will be held from November 1-3\, 2024 at Stockholm\, Sweden. \nESH (European School of Haematology)’s ‘How to Diagnose and Treat’ meetings are specialized\, disease-specific events designed to provide in-depth insights into the latest advances in diagnostics and clinical management of various hematological conditions. These meetings focus on the presentation and analysis of real-life clinical cases\, offering attendees a practical\, case-based learning experience. \nInteractive voting technology is incorporated as a self-assessment tool\, enabling participants to evaluate their understanding while fostering increased scientific engagement and discussion. Through this approach\, ESH promotes a dynamic exchange of ideas between experts and clinicians\, helping to advance best practices in patient care. \nFor more information and registration visit here
URL:https://oncodaily.com/event/165584
LOCATION:Hotel Clarion\, Ringvägen 98\, Stockholm\, 10460\, Sweden
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/7.-LYMPHOMA-2024-ShockLogic-e1729018656497.png
ORGANIZER;CN="European School of Haematology":MAILTO:info(at)esh.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241024T163000
DTEND;TZID=Europe/Helsinki:20241027T123000
DTSTAMP:20260404T101947
CREATED:20241022T200624Z
LAST-MODIFIED:20250608T081100Z
UID:10000057-1729787400-1730032200@oncodaily.com
SUMMARY:COSTEM 2024
DESCRIPTION:The 9th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2024 will be held at Berlin\, Germany from October 24-27\, 2024. \nCOSTEM 2024 continues to drive innovation and push the boundaries\, establishing itself as a forward-thinking\, influential\, and informative congress. As a platform for cutting-edge discussions\, COSTEM provides a unique opportunity for healthcare professionals\, researchers\, and industry experts to engage with the latest advancements and controversies in stem cell transplantation and cellular therapies. Attendees will be exposed to a wide array of viewpoints\, with thought-provoking debates that encourage critical thinking and challenge conventional approaches. This interactive and progressive congress not only highlights emerging research and clinical practice innovations but also serves as a vital forum for exploring divergent perspectives and refining treatment approaches for the future. \nFor registration visit here
URL:https://oncodaily.com/event/170118
LOCATION:Hotel nhow\, Berlin\, Stralauer Allee 3\, Berlin\, 10245\, Germany
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/download-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241024T000000
DTEND;TZID=Europe/Helsinki:20241025T000000
DTSTAMP:20260404T101947
CREATED:20241022T200543Z
LAST-MODIFIED:20250608T081108Z
UID:10000060-1729728000-1729814400@oncodaily.com
SUMMARY:The 9th MD Anderson Cancer Center International Meeting In Gynecologic Oncology
DESCRIPTION:The 9th MD Anderson Cancer Center International Meeting In Gynecologic Oncology will be held from October 24-25th\, 2024 at Madrid\, Spain. \nThe 9th MD Anderson Cancer Center International Meeting in Gynecologic Oncology will focus on the latest advancements in gynecologic cancer treatment\, research\, and care. Bringing together experts from around the world\, the meeting will provide a platform for discussions on innovative therapies\, clinical trials\, and multidisciplinary approaches to improving outcomes for patients with gynecologic cancers. Attendees will have the opportunity to engage with cutting-edge science and collaborative efforts in the field of gynecologic oncology. \n 
URL:https://oncodaily.com/event/170894
LOCATION:Auditorio Fundación MD Anderson Cancer Center Spain\, Calle Arturo Soria\, 329\, Madrid\, 28033\, Spain
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/MD-ANderson-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241023T000000
DTEND;TZID=Europe/Helsinki:20241025T000000
DTSTAMP:20260404T101947
CREATED:20241017T182233Z
LAST-MODIFIED:20250608T081055Z
UID:10000047-1729641600-1729814400@oncodaily.com
SUMMARY:36th EORTC-NCI-AACR Symposium
DESCRIPTION:36th EORTC-NCI-AACR Symposium will be held at Barcelona\, Spain from October 23-25\, 2024. \nHosted by the European Organisation for Research and Treatment of Cancer (EORTC)\, the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR)\, the 2024 Symposium attracts academics\, scientists and pharmaceutical industry representatives from across the globe to discuss the latest innovations in drug development\, target selection and the impact of new discoveries in molecular biology. \nENA 2024 stands as the drug development and translational research meeting\, giving the spotlight to preclinical and phase I studies\, ensuring in-depth scientific discussions on the latest developments in targets and drugs. \nFor Registration Visit Here
URL:https://oncodaily.com/event/166975
LOCATION:Centre de convencions internacional Bacerlona\, Plaça de Willy Brandt\, 11-14\, Barcelona\, 08019\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/ENA_900x400-1.jpg
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241018T084500
DTEND;TZID=America/Halifax:20241018T205500
DTSTAMP:20260404T101947
CREATED:20240929T170455Z
LAST-MODIFIED:20250608T081049Z
UID:10000008-1729241100-1729284900@oncodaily.com
SUMMARY:NFCR Global Summit and Award Ceremonies For Cancer Research and Entrepreneurship
DESCRIPTION:The Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship is a special event where some of the brightest minds in oncology\, research\, and entrepreneurship come together to change the future of cancer treatment. Organized by the National Foundation for Cancer Research\, it’s all about building a community of scientists\, innovators\, survivors\, and industry leaders who are passionate about advancing cancer research and saving lives. \nAt the summit\, attendees will hear from inspiring speakers\, take part in lively panel discussions\, and explore the latest breakthroughs and future trends in cancer care. It’s a fantastic chance to connect with key figures in the field and collaborate on new ideas that could make a real difference. \nThis year’s Global Summit will take place on Friday\, October 18\, 2024\, at the National Press Club in Washington\, D.C.
URL:https://oncodaily.com/event/global-summit153172
LOCATION:National Press Club in Washington\, D.C\, 529 14th St NW\, Washington\, DC 20045\, Washington
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/09/IMG_9315-1.png
ORGANIZER;CN="National Foundation for Cancer Research":MAILTO:info@nfcr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20241017T090000
DTEND;TZID=Europe/Paris:20241020T130000
DTSTAMP:20260404T101947
CREATED:20241007T195204Z
LAST-MODIFIED:20250608T081043Z
UID:10000018-1729155600-1729429200@oncodaily.com
SUMMARY:EANO2024: 19th Meeting of the European Association of Neuro-Oncology
DESCRIPTION:The 19th Meeting of the European Association of Neuro-Oncology (EANO 2024) will be held in Glasgow\, UK on October 17-20. The event will begin with an Educational Day on Thursday\, October 17\, followed by the main program starting on Friday\, October 18. \nThis congress is a great opportunity for professionals across various fields—including Neuro-Oncology\, Neurosurgery\, Neuropathology\, Neuroradiology\, Radiation Oncology and Nursing—to exchange ideas and collaborate. \nAttendees will hear from global experts presenting the latest outcomes from clinical trials and highlighting significant advances in both basic and translational science. \nKey themes for this year’s meeting will include experimental and combination therapies\, innovations in radiation oncology technologies\, precision neurosurgical tools\, advanced imaging techniques\, and breakthroughs in molecular diagnostics. \nDon’t miss this chance to enhance your knowledge and contribute to the future of CNS tumor management! Register here.
URL:https://oncodaily.com/event/eano2024160048
LOCATION:Scottish Event Campus\, Exhibition Way\, Glasgow G3 8YW\, Glasgow\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/1111.jpg
ORGANIZER;CN="EANO European Association of Neuro-Oncology":MAILTO:eano-meetings@eano.eu
END:VEVENT
END:VCALENDAR